Basic research on hyperpolarized MR imaging (DNP-MRI) using urologic cancer tissue

Not Applicable

• Conditions: Prostate cancer, bladder cancer, kidney cancer

• Registration Number: JPRN-jRCT1040220135
• Lead Sponsor: nakae Keita

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-06
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

(1) Patients over 20 years of age with suspected prostate cancer or bladder cancer or renal cancer
(2) Inpatients and outpatients
(3) Patients who give written consent to participate in this study

Exclusion Criteria

(1) Patients under 20 years old
2) Patients with suspected prostate cancer but no prostate cancer is suspected by MRI scan.
3) Patients with bladder cancer whose bladder cancer cannot be confirmed by the naked eye
(iv) Patients whose cancer is small and the collection of samples for the study may interfere with diagnosis and treatment.
(5) Patients whose consent to participate in this study was not obtained in writing.
(iv) Patients who are judged to be ineligible for participation in this study by the principal investigator or subinvestigator of the medical institution where this study is conducted.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tissue metabolic analysis of DNP-MRI and DNP probes in normal and cancer ancestral tissues by ESR